This article discusses the importance and effectiveness of viscoelastic hemostatic assays
(VHAs) in assessing hemostatic competence and guiding blood component therapy (BCT) in …

Abstract United States Food and Drug Administration (FDA)‐approved viscoelastic testing
(VET) methodologies have significantly changed in the last 10 years, with the availability of …

A unique coagulopathy often manifests following traumatic brain injury, leading the clinician
down a difficult decision path on appropriate prophylaxis and therapy. Conventional …

Background Hemorrhage is a leading cause of preventable death in civilian and military
trauma. Freeze‐dried plasma is promising for hemostatic resuscitation in remote prehospital …

Uncontrolled bleeding is the leading cause of preventable death following injury. Trauma-
induced coagulopathy can manifest as diverse phenotypes ranging from hypocoagulability …

Hemorrhage remains the leading cause of potentially preventable trauma death worldwide.
1, 2 Since the 1980s, resuscitation strategies in the hemorrhaging patient centered around …

Trauma-induced pulmonary thromboembolism is the second leading cause of death in
severe trauma patients. Primary fibrinolytic hyperactivity combined with hemorrhage and …

Compared with conventional coagulation tests and factor-specific assays, viscoelastic
hemostatic assays (VHAs) can provide a more thorough evaluation of clot formation and …

Uncontrolled and massive bleeding with derangement of coagulation is a major challenge in
the management of both surgical and seriously injured patients. The underlying mechanism …

There has been a significant interest in the last decade in the use of viscoelastic tests (VETs)
to determine the hemostatic competence of bleeding patients. Previously, common …